ctDNA and MRI Parameters in Head and Neck Cancer
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age19-100
SponsorFranziska Eckert
About this trial
Patients undergoing primary radiochhemotherapy for locally advanced head and neck squamous cell carcinomas are included in this study. In addition to standard of care treatment patients will undergo addiational blood draws and MR imaging studies. Circulating cell free tumor DNA will be analysed in the blood samples. BIological data, imaging data and clinical data (such as patient and tumor characteristics, oncologic outcome, side effects) will be analysed in a biomathematical modelling approach.
Eligibility criteria
Qualifiers
Squamous cell carcinoma head and neck
Planned primary platinum based radiochemotherapy
ECOG 0-2
Disqualifiers
Palliative therapy intent
Not MR eligible
Trial design
Treatments tested in this trial
- Blood draw, MRI
Treatment groups
No treatment groups listed
Locations
Sponsors and collaborators
Franziska Eckert
Lead sponsor
Medical University of Vienna
Sponsor institution
Source ClinicalTrials.gov